Tci Wealth Advisors, Inc. Inovio Pharmaceuticals, Inc. Transaction History

Tci Wealth Advisors, Inc.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 19, 2022	BUY	$1.44 - $3.98 $2,422 - $6,694	1,682 New	1,682 $3,000
Q4 2021 Jan 24, 2022	SELL	$4.99 - $7.46 $1,891 - $2,827	-379 Closed	0 $0
Q3 2021 Oct 29, 2021	SELL	$7.16 - $9.69 $179 - $242	-25 Reduced 6.19%	379 $3,000
Q2 2021 Aug 02, 2021	BUY	$6.23 - $10.03 $1,333 - $2,146	214 Added 112.63%	404 $4,000
Q1 2021 Apr 29, 2021	BUY	$8.81 - $16.96 $1,673 - $3,222	190 New	190 $2,000
Q4 2018 Jan 17, 2019	SELL	$3.89 - $6.11 $11,670 - $18,330	-3,000 Closed	0 $0
Q1 2018 Apr 30, 2018	BUY	$4.05 - $5.69 $4,050 - $5,690	1,000 Added 50.0%	3,000 $14,000
Q4 2017 Feb 01, 2018	BUY	$4.13 - $6.68 $8,260 - $13,360	2,000 New	2,000 $8,000
Q3 2017 Oct 24, 2017	SELL	$5.36 - $6.37 $536 - $637	-100 Closed	0 $0
Q2 2017 Aug 10, 2017	BUY	N/A	100	100 $1,000

281K

Ticker INO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 249,400,000
Market Cap $506M
Description
Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA se...

Get notified when there are updates to the investment portfolio of Tci Wealth Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Tci Wealth Advisors, Inc. with notifications on news.